The UCLA spinout will expand its commercialisation efforts and continue its research into brain health conditions.

Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer are supporting the newly launched Swiss healthcare accelerator.

The fund, backed by Tsinghua Unigroup, will support the growth of industries including high-end manufacturing, IT, aerospace, new energy, new materials, pharmaceuticals and internet-related services.

Frequency Therapeutics is working on a progenitor cell-related treatment for hearing loss based on research conducted at MIT and Harvard Medical School.

UPMC and Philips have co-led a funding round for ALung Technologies, a Pittsburgh University spinout working on treatments for acute respiratory failure.

Zaluvida has boosted the series A round raised by Targedys, which is working on products to regulate the appetite, to a total of $11.1m over the past year.

Frequency Therapeutics, which is working on a progenitor cell-related treatment for hearing loss, has closed a round featuring Alexandria Real Estate Equities.

Sanofi and Takeda-backed Ovid Therapeutics has filed to raise $86.3m in an initial public offering and plans to use the proceeds to advance its neurological disease treatments.

The Bristol University Enterprise Fund has joined a series B round for SetSquared portfolio business Micrima.

Philips and UPMC have co-led a funding round for ALung Technologies, a Pittsburgh University spinout working on treatments for acute respiratory failure.